Fact CheckerSign in

NCT07461805Recruiting

Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features

Caracterización de Subgrupos de Personas Con Diabetes Tipo 1: análisis de características clínicas y glucométricas Utilizando Una aproximación de Inteligencia Artificial

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is: Are there distinct subtypes among people with type 1 diabetes? Participants will be invited to take part in the study by allowing access to their health data. They will not be required to undergo any additional examinations, tests, visits, or interventions.

Status (registry)
Recruiting
Study type
Observational
Enrollment
800 (estimated)
First submitted
14 Nov 2025
Start date
4 Nov 2025
Primary completion date
Jun 2028
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
NCT number
NCT07461805

What you commit to

  • Study type: Observational
  • Planned participants: 800
  • From 4 Nov 2025 to the primary completion date, Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of severe comorbidities or medical conditions that, in the investigator's judgment, could interfere with participation in the study or the interpretation of results. This circumstance is expected to be exceptional, as the study aims to be as inclusive as possible.

Who the study is looking for

  • Individuals with type 1 diabetes (T1D) aged 18 years or older.
  • T1D individuals expected to have regular follow-up at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau.
  • Users of continuous glucose monitoring (CGM) systems for at least the last 6 months of 2024.
  • Willingness and ability to provide written informed consent to participate in the study (by the patient or his/her representative).

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona 08041
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.